Pivotal bioVenture Partners Investment Advisor LLC - Q1 2021 holdings

$312 Million is the total value of Pivotal bioVenture Partners Investment Advisor LLC's 9 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 22.2% .

 Value Shares↓ Weighting
KRTX SellKARUNA THERAPEUTICS INC$109,254,000
-0.7%
908,708
-16.1%
35.05%
-3.4%
BOLT NewBOLT BIOTHERAPEUTICS INC$62,248,0001,891,467
+100.0%
19.97%
INZY  INOZYME PHARMA INC$31,505,000
-4.1%
1,591,1540.0%10.11%
-6.6%
PCVX SellVAXCYTE INC$27,757,000
-53.0%
1,405,421
-36.8%
8.90%
-54.3%
AKUS  AKOUOS INC$24,884,000
-30.1%
1,794,0880.0%7.98%
-31.9%
ALGS  ALIGOS THERAPEUTICS INC$19,933,000
-17.8%
876,5480.0%6.40%
-20.0%
FUSN  FUSION PHARMACEUTICALS INC$17,135,000
-8.8%
1,598,3790.0%5.50%
-11.2%
ARQT SellARCUTIS BIOTHERAPEUTICS INC$16,462,000
-12.9%
569,041
-15.3%
5.28%
-15.2%
ETTX SellENTASIS THERAPEUTICS HLDGS I$2,517,000
-13.7%
1,176,378
-0.3%
0.81%
-15.9%
ITRM ExitITERUM THERAPEUTICS PLC$0-945,085
-100.0%
-0.31%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
KARUNA THERAPEUTICS INC12Q3 202365.4%
VAXCYTE INC12Q3 202319.5%
INOZYME PHARMA INC12Q3 202310.8%
ARCUTIS BIOTHERAPEUTICS INC12Q3 20236.2%
FUSION PHARMACEUTICALS INC12Q3 20236.2%
ALIGOS THERAPEUTICS INC12Q3 20238.0%
BOLT BIOTHERAPEUTICS INC11Q3 202320.0%
RALLYBIO CORP9Q3 202314.1%
AKOUOS INC8Q3 202211.7%
EXSCIENTIA PLC8Q3 20236.4%

View Pivotal bioVenture Partners Investment Advisor LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-13
13F-HR2023-08-11
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-10
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-14
13F-HR2021-11-15

View Pivotal bioVenture Partners Investment Advisor LLC's complete filings history.

Compare quarters

Export Pivotal bioVenture Partners Investment Advisor LLC's holdings